期刊文献+

糖尿病肾病脑动脉硬化患者血清β_2-微球蛋白、基质金属蛋白酶-2水平分析 被引量:3

下载PDF
导出
摘要 目的:分析糖尿病肾病脑动脉硬化患者血清β2-微球蛋白(β2-MG)和基质金属蛋白酶-2(MMP-2)水平变化。方法:将80例糖尿病肾病患者分为脑动脉硬化组(48例)和脑动脉正常组(32例),分别检测两组血清β2-MG和MMP-2水平,并行组间比较分析。结果:脑动脉硬化组β2-MG水平较脑动脉正常组明显升高,而MMP-2水平较脑动脉正常组明显降低(P均<0.05)。结论:糖尿病肾病患者血清β2-MG、MMP-2异常可能与其脑动脉硬化有关。
出处 《微循环学杂志》 2013年第1期26-27,I0001,共3页 Chinese Journal of Microcirculation
  • 相关文献

参考文献4

二级参考文献41

  • 1胥缘美,施荷玉.单纯TCD峰时后延评价脑动脉硬化的临床意义[J].中国超声诊断杂志,2004,5(10):727-728. 被引量:2
  • 2董凤芹,李红,蔡卫民,陶君,李群,阮昱,郑芬萍,张哲.吡格列酮对糖尿病大鼠肾组织基质金属蛋白酶2和9表达的影响[J].中华内分泌代谢杂志,2004,20(5):459-460. 被引量:17
  • 3曲延顺,庄丽.经颅多普勒超声PI值对高血压脑动脉硬化的价值[J].新疆医学,2005,35(3):16-18. 被引量:3
  • 4黄向阳,王英,刘倩,罗春娥.血清胱抑素C检测与肾功能关系的临床研究[J].中国实验诊断学,2007,11(6):801-802. 被引量:17
  • 5中华神经精神科杂志编委会.脑动脉硬化症诊断标准[J].中华神经精神科杂志,1978,11:128-128.
  • 6Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies: part Ⅰ. Circulation,2003,108 ( 14 ) : 1664 - 1672.
  • 7Zeng B,Prasan A,Fung KC,et al. Elevated circulating levels of matrix metalloproteinase -9 and -2 in patients with symptomatic coronary artery disease. Intern Med J,2005,35 ( 6 ) :331 - 335.
  • 8Handa N, Matsumotom, Maede H, et al, lsehemic stroke events and caeotid atherosclerosis. Stroke, 1995,26 ( 10 ) : 1781 - 1786.
  • 9Jo Y, Ycon J, Kim HJ,et al. Analysis of tissue inhibitor of metalloproteinases- 2 effect on pro- matrix metalloproteinase- 2 activation by membrane - type 1 matrix metalloproteinase using baculovirus/insect - cell expression system. Biochem J,2000,345 : 511 - 519.
  • 10Lee E, Grodzinsky A J, Libby P,et al. Human vascular smooth muscle cell- monocyte interactions and metalloproteinase secretion in culture. Arterioscler Thromb Vasc Biol, 1995,15:2284 - 2289.

共引文献52

同被引文献33

  • 1周秀艳,侯振江,李艳华,邢桂芝,张庆峰,韩素桂,于文霞,楮金龙.血清基质金属蛋白酶-2及其组织抑制因子-1与糖尿病高血压和肾病的相关性研究[J].中国老年学杂志,2006,26(4):458-460. 被引量:7
  • 2汪露祥,吴强,丁向东,杨枫,蒋振,吴献忠.MMP-9、TIMP-1及MMP-2、TIMP-2表达与胃肠道间质瘤生物学行为的关系[J].中国基层医药,2006,13(6):928-930. 被引量:5
  • 3赵向彤,潘优津,吴朝明,李莉丽,郑超,吴笑英.2型糖尿病肾病患者基质金属蛋白酶-2水平变化及其临床意义[J].温州医学院学报,2006,36(5):489-490. 被引量:7
  • 4Izumi Y,Satterfield K,Lee S. Risk of reamputation in diabetic patients stratified by limb and level of amputation:A 10-year observation[J].Diabetes Care,2006,(03):566-570.doi:10.2337/diacare.29.03.06.dc05-1992.
  • 5Apelqvist J,Bakker K,van Houtum WH. International consensus and practical guidelines on the management and the prevention of the diabetic foot.International Working Group on the Diabetic Foot[J].Diabetes/Metabolism Research and Review,2000,(Suppl 1):S84-S92.
  • 6Lavery LA,Armstrong DG,Harkless LB. Classification of diabetic foot wounds[J].Journal of Foot and Ankle Surgery,1996,(06):528-531.
  • 7Singhania N,Puri D,Madhu SV. Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy[J].Quarterly Journal of Medicine,2008,(06):449-445.
  • 8Hanna BC,Delap TG,Scott K. Surgical debridement of craniocervical necrotizing fasciitis:the window of opportunity[J].Journal of Laryngology & Otology,2006,(08):702-704.
  • 9Patricia AM,Snoek-van B,Johannes W. Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors[J].Biotechniques,2005,(01):73-83.doi:10.2144/05381RV01.
  • 10Lobmann R,Ambrosch A,Schultz G. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients[J].Diabetologia,2002,(07):1011-1016.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部